David Weinreich

David Weinreich

Chief Tech/Sci/R&D Officer at MERCK KGAA
Health Technology
Consumer Services
Finance

Profile

David is an operating partner at Foresite Labs, and also serves as senior advisor at Foresite Capital.
With more than 20 years of expertise in clinical development, drug commercialization and advancing therapies for patients in need, David supports Foresite Labs’ incubated companies, particularly their translational and clinical research commitments, and explores and initiates new programs and company concepts.
David joined Foresite Labs from Regeneron, where he was the executive vice president and head of global clinical development.
During his tenure with the company, David managed programs across different therapeutic focus areas, including its successful Dupixent program and its COVID therapeutic antibody.
Prior to Regeneron, he was the head of global development for specialty medicine at Bayer Pharmaceuticals and previously served as executive director and global product area leader (Angiogenesis) at Amgen.
BS in Computer Engineering from Columbia University Executive MBA from Georgetown University MD from Boston University School of Medicine

David Weinreich active positions

CompaniesPositionStart
MERCK KGAA Chief Tech/Sci/R&D Officer 2025-08-27

Former positions of David Weinreich

CompaniesPositionEnd
Consultant / Advisor 2025-06-30
Private Equity Investor 2025-06-30
REGENERON PHARMACEUTICALS, INC. Private Equity Investor 2023-07-31
Bayer Pharmaceuticals Corp.
Private Equity Investor 2016-01-31
AMGEN INC. Private Equity Investor 2012-05-31
See the detail of David Weinreich's experience

Training of David Weinreich

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Bayer Pharmaceuticals Corp.

Consumer Services

Consumer Services

Finance

Consumer Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. David Weinreich